The study, which is based on about 80,000 Danish cases of skin cancer, shows that the risk of developing skin cancer is up to seven times greater for users of medicine containing Hydrochlorothiazide.

A Photosensitizing Drug and Risk for Skin Cancer. Cutaneous squamous cell carcinoma (cSCC) and basal cell carcinoma (BCC)—collectively termed nonmelanoma skin cancers (NMSC)—are the most ...

(HealthDay)—Use of the diuretic hydrochlorothiazide is associated with a substantially increased risk of non-melanoma skin cancer, according to a study published in the April issue of the ...

Patients treated with hydrochlorothiazide for hypertension may face an increased risk for certain skin cancers with longer duration of use, according to a study.“Hydrochlorothiazide (HCTZ) is ...

New data add strength to prior observations that long-term exposure to thiazide diuretics is associated with a higher risk of developing some types of skin cancer. Recently, Health Canada , the US ...

High use of hydrochlorothiazide (≥50,000mg) ... (2004 to 2012), the authors identified cases with non-melanoma skin cancer and matched them by age and sex in a 1-to-20 ratio to controls.

OTTAWA, Jan. 31, 2019 /CNW/ - Health Canada has completed a safety review of hydrochlorothiazide and has found that prolonged use of the drug could increase a person's risk for non-melanoma skin ...

Patients initiating hydrochlorothiazide or other photosensitizing agent need a reminder about simple measures to avoid sun exposure, researchers say. News & Perspective Drugs & Diseases ...